|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
11682 El Camino Real, Suite 300, San Diego, CA 92130, US
|
|
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceuticals company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The Company’s SYMJEPI® (epinephrine) Injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The Company’s ZIMHI™ (naloxone) Injection product is approved for the treatment of opioid overdose. Tempol is in development for the treatment of patients with COVID-19 and a Phase 2/3 clinical trial is underway. https://www.adamispharmaceuticals.com/social-media/
|
Adamis Pharmaceuticals Corporation Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Adamis Pharmaceuticals Corporation email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Adamis Pharmaceuticals Corporation customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.